商品簡介
Hollingsworth offers a comprehensive examination of the screening controversy informing efforts to either expand or curtail breast cancer screening, genetic testing, and high-risk interventions. The book covers the biology behind early screening for breast cancer, the history of breast cancer diagnosis and treatment, and the ongoing controversy over early screening and other diagnosis issues, arguing for the life-saving power of mammography in early screening. The author is with Mercy Hospital of Oklahoma City, Oklahoma. Annotation ©2016 Ringgold, Inc., Portland, OR (protoview.com)
作者簡介
Alan B. Hollingsworth, M.D., serves as medical director of Mercy Breast Center, a screening and diagnostic facility at Mercy Hospital, Oklahoma City. He received his MD with Distinction from the University of Oklahoma College of Medicine in 1975 where he was elected First vice-president of Alpha Omega Alpha Honor Medical Society. He completed a residency in general surgery at the University of Oklahoma that included a one-year fellowship in surgical pathology at UCLA. He limited his practice to breast cancer surgery in the 1980s and was the founding medical director of Oklahoma’s first multidisciplinary breast clinic at his alma mater where he was also named as the first holder of the G. Rainey Williams Chair in Surgical Breast Oncology. He was one of the first physicians in the country to begin a formal risk assessment program in 1993, and today his practice is limited to risk assessment, genetic testing, and multimodality screening for high-risk patients.